Home  Products Search  Properties Search  中文版
Home > Dictionary > Information
2-[1-(Ethoximino)butyl]-5-[2-(ethylthio)-propyl]-3-hydroxy-2-cyclohexen-1-one;2-[1-(Ethoxyimino)butyl]-5-[2-(ethylthio)propyl]-3-hydroxy-2-cyclohexen-1-one;Sethoxydim
Molecular formula : C17H29NO3S
MW : 327.48
CAS No. :74051-80-2

nature : density 1.043. >90 ° C melting point.


Notice:Each item can have many explanations from different angels. If you want grasp the item comprehensively,please see below "more details data".
Structure:
More Detailed Data:
1) Sethoxydim;2-[1-(Ethoxyimino)butyl]-5-[2-(ethylthio)propyl]-3-hydroxy-2-cyclohexen-1-one;Poast
2) sethoxydim
3) sethoxydim
4) Dilute Wo determined
5) 2-(1-(ethoxyimino)butyl)-5-(2-(ethylthio)propyl)-3-hydroxy-2-Cyclohexen-1-one;2-(1-(ethoxyimino)butyl)-5-(2-(ethylthio)propyl)-3-hydroxy-2-cyclohexen-1-one
6) 4,4'-diethoxythio-carbanilid;4,4'-diethoxythiocarbanilide;aethoksid;ethoxide (pharmaceutical);ethoxyd;etocarlide;etoksid;n,n'-bis(4-ethoxyphenyl)thiourea
7) Cyclohex-2-enone;2-Cyclohexen-1-one
8) 2-Cyclohexen-1-one;2-cyclohexenone
9) olefine ketone;ketene(s)
10) olefine ketone;ketene(s)
Notice Some description was translated by software and the data is only as a reference.
Patent:
1) Means for stimulation and activation of hair growth by il-15
2) Protein drug sustained-release microparticle preparation for injection and process for producing the same
3) Use of hydroxylated amino acids for treating diabetes
4) Allogeneic tumor therapeutic agent
5) Vaccine comprising an angiomotin or a polynucleotide encoding an angiomotin and its use for the treatment of angiogenic-related disorders
6) Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
7) Method of regulating phosphorylation of sr protein and antiviral agents comprising sr protein activity regulator as the active ingredient
8) Methods of modulating cytokine activity, related reagents
9) Soft capsule preparation
10) Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same